Lv2
110 积分 2023-09-24 加入
Efficacy and Tolerance of Carboplatin plus Cetuximab (Simplified EXTREME Regimen) in Patients with Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
15小时前
待确认
Real-world Data of Paclitaxel and Cetuximab in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
15小时前
已完结
First‐line cetuximab + platinum‐based therapy for recurrent/metastatic head and neck squamous cell carcinoma: A real‐world observational study—ENCORE
16小时前
已完结
Cetuximab Treatment beyond Progression in Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: A Nationwide Population-Based Study (THNS-2021-08)
16小时前
已完结
Clinical outcomes of cetuximab‐based treatment for distant metastatic head and neck squamous cell carcinoma: A real‐world study using Taiwan Head Neck Society registry database
16小时前
已关闭
Pembrolizumab in the first-line treatment of advanced head and neck cancer
16小时前
已完结
Systemic treatment of recurrent and/or metastatic squamous cell carcinomas of the head and neck: what is the best therapeutic sequence?
17小时前
已完结
Trends in the approval of cancer therapies by the FDA in the twenty-first century
5天前
已完结
Trends in the approval of cancer therapies by the FDA in the twenty-first century
5天前
已完结
皖公网安备34019202002308
